EOS imaging has announced the change of its leadership effective 1 January 2019. The Board of Directors, in agreement with Marie Meynadier, chief executive officer of EOS imaging, has decided to change the leadership of the company to strengthen the company’s presence in the USA, its largest market, and expand its shareholder base.
The board has unanimously appointed Mike Lobinsky, who joined the company in August 2017 as president North America, to the position of chief executive officer effective 1 January 2019. Marie Meynadier will continue as chief executive officer of EOS imaging until December 31, 2018 and thereafter retains a position on the Board of Directors. Also being considered is Mike Lobinsky’s nomination to director of EOS imaging at a subsequent shareholder general meeting.
Mike Lobinsky has over twenty years’ experience in the medtech industry with senior management roles in sales, marketing, operations and business development in the fields of orthopaedic robotics, navigation, imaging and implants. He has held leadership positions at Smith and Nephew, Brainlab, Blue Belt Technologies, Stryker and most recently contributed to the acquisition of Blue Belt by S&N prior to joining EOS in 2018.
Marie Meynadier, chief executive officer of EOS Imaging, said, “I have enjoyed working with Mike for over a year. His leadership and knowledge of the industry, combined with his fine understanding of corporate culture, are excellent assets for EOS imaging and I have complete confidence in his ability to continue and accelerate the development of the company.”
Gérard Hascoet, chairman of the Board of Directors of EOS imaging, commented: “Marie’s vision, her energy and her remarkable managerial talent have brought EOS imaging to a stage of excellence and a unique international reputation. Marie has given the company access today to an acceleration opportunity in the United States, which is a new step.”
Mike Lobinsky, president North America, EOS imaging, added: “I am very grateful to Marie and the board members for their trust and pleased to accept the CEO position. Few companies have accomplished what EOS has and these achievements have established a strong foundation for further development.”
Valérie Worrall also joins the company as chief financial officer. Valérie Worrall has more than twenty years of experience in leadership finance roles and as the CFO within business units in the healthcare industry. She has held positions in South East Asia, the USA, Switzerland, the UK, and France. She most recently was CFO of Balt, a medical device company.